Pediatrics in Rhode Island

Synapse Dental manufactures the Dental Pain Eraser, an FDA-cleared electronic dental anesthesia device that uses patent-pending Advanced Pulsewave Technology™ to deliver gentle electric pulses that block dental pain and reduce patient anxiety. The portable device eliminates the need for traditional needle injections in many procedures, providing pain relief even before patients enter the operatory chair. The Dental Pain Eraser is validated across multiple dental disciplines including orthodontics, oral surgery, pediatric dentistry, general restorative dentistry, endodontic therapy, and maxillofacial trauma repair. The company has published clinical evidence in peer-reviewed journals (Journal of Clinical Orthodontics, Lasers in Medical Science, International Journal of Paediatric Dentistry) demonstrating efficacy in reducing pain and anxiety, eliminating needles in restorative procedures, and managing pain during pulpotomy in pediatric patients. The device has received multiple industry awards including three consecutive American Association of Orthodontists (AAO) New Products Showcase Awards (2023–2025), the AAO Ortho Innovator Award, Cellerant's Best of Class Hygiene Award, and the Ortho Townie Choice Award. The Delta Rail tip accessory delivers enhanced anesthesia for more invasive procedures. Synapse Dental markets the Dental Pain Eraser as a practice differentiator that improves patient comfort, increases treatment acceptance rates, and enhances practice efficiency by reducing chair time. The device is suitable for general dentists, orthodontists, pediatric dentists, and oral surgeons.

SmolTap, Inc. manufactures the SMöLTAP, an innovative positioning cradle designed to simplify and improve infant lumbar punctures (spinal taps). The device uses gravity-assist positioning, pelvis-tipping mechanics, and secure infant stabilization to increase first-stick success rates, reduce failed procedures, and lower associated hospitalization risk. SMöLTAP addresses a critical clinical gap—approximately 38% of traditional infant LPs fail due to positioning difficulties—by enabling healthcare teams to focus on procedure accuracy and infant comfort rather than manual positioning. The solution improves clinical consistency, reduces staff workload and stress, and enhances patient and family experience across emergency departments, PICUs, NICUs, cancer centers, operating rooms, and interventional radiology settings. Winner of the 2025 SWPDC & AAP (SOATT) Pediatric Device Prize and deployed in major U.S. and Canadian pediatric hospitals including SickKids, Boston Children's, Mayo Clinic, and Philadelphia Children's Hospital.

Sentec AG manufactures noninvasive monitoring solutions for critical care, intensive care, and neonatal settings. The company specializes in transcutaneous monitoring (TCM) technology that enables continuous, accurate measurement of blood gases without invasive arterial puncture, supporting ventilation titration and weaning protocols. Sentec's product portfolio includes the IPV® 1 (Intrapulmonary Percussive Ventilation), a portable, lightweight respiratory therapy device with simplified clinical interfaces; and the LuMon™ System, which uses Electrical Impedance Tomography (EIT) for real-time, noninvasive visualization of regional lung function at the bedside with automatic patient position tracking. The company emphasizes reducing painful procedures in vulnerable populations, particularly neonates in the NICU, by minimizing the need for frequent blood draws while maintaining clinical accuracy. Sentec maintains a global distribution network with regional customer service offices across North America, Europe, Australia, and Asia-Pacific. The company adheres to medical device quality standards and regulatory requirements appropriate to its markets. Products are designed for hospital ICUs, NICUs, and acute care settings where continuous respiratory and gas monitoring inform clinical decision-making and patient safety protocols.